149 related articles for article (PubMed ID: 2527626)
1. [Preliminary study of two inbred mice models for infection and immunity of Brucellosis].
Zhang JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):18-24. PubMed ID: 2527626
[TBL] [Abstract][Full Text] [Related]
2. [A pathohistological study on experimental brucellosis in inbred mice].
Li HZ
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):134-6. PubMed ID: 1914022
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
4. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and Brucella.
Baldwin CL; Winter AJ
Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
[TBL] [Abstract][Full Text] [Related]
6. Outcome and immune responses after Brucella abortus infection in young adult and aged mice.
High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N
Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
8. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection.
Pasquali P; Adone R; Gasbarre LC; Pistoia C; Ciuchini F
Infect Immun; 2001 Oct; 69(10):6541-4. PubMed ID: 11553603
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
10. An enzyme immunoassay for bovine brucellosis using a monoclonal antibody specific for field strains of Brucella abortus.
Gorrell MD; Milliken GL; Anderson BJ; Pucci A
Dev Biol Stand; 1984; 56():491-4. PubMed ID: 6436107
[TBL] [Abstract][Full Text] [Related]
11. [Development of Brucella abortus, Brucella melitensis and Brucella and Brucella suis infection infection in mice to a chronic stage and cure].
Bosseray N; Plommet M; De Rycke J
Ann Rech Vet; 1982; 13(2):153-61. PubMed ID: 7168538
[No Abstract] [Full Text] [Related]
12. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.
Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC
Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355
[TBL] [Abstract][Full Text] [Related]
13. Antigenic differences between Brucella abortus and Brucella melitensis recognized by a monoclonal antibody.
Cappuccinelli P; Fiori PL; Gargani G; Pacetti AM
Microbiologica; 1986 Apr; 9(2):179-88. PubMed ID: 2423851
[TBL] [Abstract][Full Text] [Related]
14. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.
Spera JM; Ugalde JE; Mucci J; Comerci DJ; Ugalde RA
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16514-9. PubMed ID: 17053080
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity.
Sathiyaseelan J; Goenka R; Parent M; Benson RM; Murphy EA; Fernandes DM; Foulkes AS; Baldwin CL
Cell Immunol; 2006 Sep; 243(1):1-9. PubMed ID: 17184756
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O:9 in pigs.
Riber U; Jungersen G
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):13-25. PubMed ID: 17270281
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
[TBL] [Abstract][Full Text] [Related]
19. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections.
Rajashekara G; Glover DA; Krepps M; Splitter GA
Cell Microbiol; 2005 Oct; 7(10):1459-73. PubMed ID: 16153245
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and cellular immunity in experimental murine brucellosis.
Cheers C
Dev Biol Stand; 1984; 56():237-46. PubMed ID: 6333362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
